Developments in the pharmaceutical industry with new formulations have led to a reevaluation of a steroid for numerous ocular conditions. The ocular steroid is generally used to prevent permanent damage to the eye, which may arise from certain eye problems.

Ocular steroid treats inflammation and relieves symptoms such as swelling, pain, redness, or irritation. In addition, ocular steroids are also used to prevent a number of complications associated with postoperative ocular inflammation. However, the two most common side effects associated with the ocular steroid are increased intraocular pressure (IOP) and cataract formation.

Rising geriatric population with the increasing incidence of eye diseases globally is expected to be the prime factor driving the growth of global ocular steroid market. In addition, growing incidences of ophthalmic diseases like cataracts are further expected to drive the growth of the global ocular steroid market. According to WHO, it is reported that cataract is the most common eye ailment which has caused blindness in 23 million individuals.

Thus it is estimated that there is the vast population to serve ocular steroid.  However, low emphasis on ophthalmology compared to other specialties due to lack of awareness is expected to hamper the growth of the global ocular steroids market. These factors are majorly responsible for driving and hampering the growth of the global ocular steroid market.

• Ocular Steroid Market Segments
• Ocular Steroid Market Dynamics
• Historical Actual Market Size, 2013 - 2017
• Ocular Steroid Market Size & Forecast 2017 to 2026
• Ocular Steroid Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Ocular Steroid Market Drivers and Restraints

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance